Evidence map›Paper›PMID 37942058›Full record

ArticleClinical medicine insights. Endocrinology and diabetes2023

Brown Tumors of the Jaws: A Retrospective Study.

Maya Fedhila, Raouaa Belkacem Chebil, Hela Marmouch, Sabrine Terchalla, Samia Ayachi, Yassine Oueslati, Lamia Oualha, Nabiha Douki, Habib Khochtali

Open access · goldAbstract read
In one paragraph

Article in Clinical medicine insights. Endocrinology and diabetes, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Maya FedhilaDepartment of Oral Medicine and Oral Surgery, Sahloul Hospital (Sousse), Faculty of Dental Medicine of Monastir, University of Monastir, Monastir Tunisia.ORCID https://orcid.org/0000-0002-5100-9908
Raouaa Belkacem ChebilDepartment of Oral Medicine and Oral Surgery, Sahloul Hospital (Sousse), Faculty of Dental Medicine of Monastir, University of Monastir, Monastir Tunisia.ORCID https://orcid.org/0000-0002-1832-3487
Hela MarmouchDepartment of Endocrinology,Fattouma Bourguiba Hospital, Faculty of Medicine of Monastir, University of Monastir,Monastir, Tunisia.
Sabrine TerchallaDepartment of Oral Medicine and Oral Surgery, Sahloul Hospital (Sousse), Faculty of Dental Medicine of Monastir, University of Monastir, Monastir Tunisia.
Samia AyachiDepartment of Maxillofacial Surgery, Sahloul Hospital (Sousse), Faculty of Medicine of Sousse, University of Sousse, Sousse, Tunisia.
Yassine OueslatiDepartment of Oral Medicine and Oral Surgery, Sahloul Hospital (Sousse), Faculty of Dental Medicine of Monastir, University of Monastir, Monastir Tunisia.
Lamia OualhaDepartment of Oral Medicine and Oral Surgery, Sahloul Hospital (Sousse), Faculty of Dental Medicine of Monastir, University of Monastir, Monastir Tunisia.
Nabiha DoukiDepartment of Conservative Dentistry, Sahloul Hospital (Sousse), Faculty of Dental Medicine of Monastir, University of Monastir, Monastir, Tunisia.
Habib KhochtaliDepartment of Maxillofacial Surgery, Sahloul Hospital (Sousse), Faculty of Medicine of Sousse, University of Sousse, Sousse, Tunisia.
University of Monastir · TNUniversity of Sousse · TN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: (1) Describe the clinical spectrum, imaging features, management, and outcome of brown tumors (BT) of the jaws. (2) Determine via a literature review the facts and controversies around the characteristics and management of this lesion. Materials and methods: Our study was approved by the institutional committee of Sahloul University Hospital in accordance with the ethical standards of the Declaration of Helsinki. Sixteen patients with BT in the context of a primary, secondary, and tertiary hyperparathyroidism were treated and followed up during their recovery. Results: This study reports 16 patients with a mean age of 48 years old. Brown tumor lesions were associated with primary hyperparathyroidism in 6 cases (38%), secondary hyperparathyroidism to chronic kidney failure in 5 cases (31%), and tertiary hyperparathyroidism in the context of a long lasting CRI in 5 cases. Their location was maxillary in 7 cases, mandibular in 5 cases, and bimaxillary in 4 cases. The treatment consisted of parathyroidectomy in 13 patients, maxillary resection in 3 cases, and vitamin D treatment in 2 cases. Favorable outcomes, characterized by tumor regression, were reported in 9 cases, whereas unfavorable evolution was observed among 7 patients. Conclusion: Parathyroidectomy is the gold standard treatment for primary hyperparathyroidism. It resulted in a total regression in all our cases. Regarding secondary hyperparathyroidism, blood screening and chronic renal insufficiency follow-up are critically valuable to detect this condition at an early stage, hence increasing the success rate of brown tumor regression. Our secondary and tertiary hyperparathyroidism results were miscellaneous; although it is important to emphasize the importance of the chronic renal insufficiency management to ensure a success. Clinical relevance: Brown tumors should be included in the differential diagnosis of giant cell lesions. Parathyroidectomy is usually sufficient to induce the total regression of the lesion in primary hyperparathyroidism cases. A more delicate approach is needed regarding secondary hyperparathyroidism. Meticulous control of chronic renal insufficiency is mandatory in addition to parathyroidectomy.

Indexed as

brown tumorshyperparathyroidismOsteitis fibrosa cysticaparathyroidectomy

Identifiers

PMID37942058
PMCPMC10629299
OpenAlexW4388467949

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.